This company says its pulsed plasma machine will deliver electricity to the grid by 2029. Some physicists warn that its ...

Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today ...

For decades, anyone who wanted to build a nuclear plant in the United States faced the same gauntlet: containment domes, ...

America is not running out of missiles, but modern war is exposing a dangerous reality: precision munitions are expensive, slow to replace, and consumed at staggering rates. From the Red Sea to Taiwan ...

Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

In February, the American Society of Clinical Psychopharmacology (ASCP) issued a series of recommendations on psychotropic drug deprescribing. 1 Derived from a Delphi survey completed by a 45-member ...

Apple's foldable iPhone is delayed due to hinge failures, as trial production stalls amid unresolved quality control issues ...

Avacta Therapeutics (AIM: AVCT, 'the Company”, 'Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a ...

Sanyou Biopharmaceuticals announced today that its independently developed AI-STAL has undergone a significant upgrade, successfully achieving a qualitative leap from "molecular treasure trove" to ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 10:30 AM EDTCompany ParticipantsSteven Stein - Executive ...

SOLV Energy Inc. reported robust revenue growth for the first quarter of 2026, with revenue reaching $677 million, marking a 66% increase year-over-year. Despite this, the company ...

Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated ...